"
Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
Marguerite (Talk | contribs) |
Marguerite (Talk | contribs) |
||
| Line 37: | Line 37: | ||
width:488px; | width:488px; | ||
height:437.5px; | height:437.5px; | ||
| - | background:rgb( | + | background:rgb(228,45,51); |
color:white; | color:white; | ||
font-size:30px; | font-size:30px; | ||
| Line 51: | Line 51: | ||
} | } | ||
.panel a { | .panel a { | ||
| - | color: rgb( | + | color: rgb(46,43,52); |
text-decoration:none; | text-decoration:none; | ||
} | } | ||
| Line 64: | Line 64: | ||
text-align:center; | text-align:center; | ||
line-height:50px; | line-height:50px; | ||
| - | background:rgb( | + | background:rgb(46,43,52); |
color:white; | color:white; | ||
} | } | ||
| Line 128: | Line 128: | ||
</a> | </a> | ||
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Drug_Screening"> | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Drug_Screening"> | ||
| - | <div id="dspanel" class="subpanel2" style="background:rgb( | + | <div id="dspanel" class="subpanel2" style="background:rgb(198,199,179); margin-bottom:12px;"> |
TARGET | TARGET | ||
</div> | </div> | ||
</a> | </a> | ||
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse"> | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse"> | ||
| - | <div id="thpanel" class="subpanel2" style="background:rgb( | + | <div id="thpanel" class="subpanel2" style="background:rgb(198,199,179); margin-right:12px;"> |
SABOTAGE | SABOTAGE | ||
</div> | </div> | ||
</a> | </a> | ||
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/TB-ception"> | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/TB-ception"> | ||
| - | <div id="tcpanel" class="subpanel2" style="background:rgb( | + | <div id="tcpanel" class="subpanel2" style="background:rgb(198,199,179);"> |
INFILTRATE | INFILTRATE | ||
</div> | </div> | ||
| Line 148: | Line 148: | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> | ||
<div class="panel"> | <div class="panel"> | ||
| - | <div class="subpanel2" style="background:rgb( | + | <div class="subpanel2" style="background:rgb(198,199,179); margin-right:12px; margin-bottom:12px;"> |
GLOBAL HEALTH | GLOBAL HEALTH | ||
</div> | </div> | ||
| - | <div class="subpanel2" style="background:rgb( | + | <div class="subpanel2" style="background:rgb(198,199,179); margin-right:12px; margin-bottom:12px;"> |
GENDER | GENDER | ||
</div> | </div> | ||
| Line 157: | Line 157: | ||
</div> | </div> | ||
| - | <div class="subpanel2" style="background:rgb( | + | <div class="subpanel2" style="background:rgb(198,199,179); margin-right:12px;"> |
BIOSENSORS | BIOSENSORS | ||
</div> | </div> | ||
| - | <div class="subpanel2" style="background:rgb( | + | <div class="subpanel2" style="background:rgb(198,199,179); margin-right:12px;"> |
OUTREACH | OUTREACH | ||
</div> | </div> | ||
Revision as of 16:07, 17 September 2013
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis affecting millions of people over the world. Using Escherichia coli as a model organism we are developing different approaches that could contribute to the fight against TB.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
An E. coli which invades macrophages and kills mycobacteria.
DETECT
TARGET
SABOTAGE
INFILTRATE
Visit our Achievements!
GLOBAL HEALTH
GENDER
BIOSENSORS
OUTREACH
Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
+33 1 44 41 25 22/25
team2013@igem-paris.org
+33 1 44 41 25 22/25
team2013@igem-paris.org 
